Skip to main content

and
  1. Article

    Neurodevelopmental and Respiratory Outcomes at 2 Years of Age in Preterm Infants Treated with Inhaled Nitric Oxide: the Euno Trial Follow Up

    Background and aims: The EUNO trial of inhaled nitric oxide (iNO) for the prevention of BPD showed similar frequencies for the primary outcome (survival without BPD at 36 weeks postmenstrual age (PMA): iNO 65.3%;...

    X Durrmeyer, H Hummler, M Sanchez-Luna, V Carnielli, D Field in Pediatric Research (2011)

  2. Article

    731 Organisation of Paediatric Emergency Care in Europe

    Paediatric Emergency Medicine (PEM) is a relatively new and rapidly evolving subspecialty, and in other parts of the world it is now established as a Board-certified paediatric subspecialty. In Europe, PEM has...

    J -C Mercier, I Maconochie, Benito J Sanchez, L Da Dalt, A Gervaix in Pediatric Research (2010)

  3. Article

    910 Sensitivity and Specificity of the Rapid Influenza Antigen Test Clearview® Exact Influenza a and B for Pandemic Iunfluenza A/H1N1 (2009)

    Reverse-transcriptase polymerase chain reaction (RT-PCR) is considered to be the reference test for diagnosis of influenza, because of its high sensitivity and specificity. Rapid Influenza Antigen Test (RIAT) ...

    F Angoulvant, J -B Dexpert, X Bellettre, J -Y Siriez, R Cohen in Pediatric Research (2010)

  4. Article

    240 Factors Influencing Neurological Outcome of Children with Bacterial Meningitis

    Background and aims: Acute bacterial meningitis is a life-threatening illness with possible long-term neurocognitive sequelae. Aim of the study was to identify clinical and biological factors associated with d...

    I D'Agostino, P Mariani-Kurkdjian, F Bargui, C Doit, N Bellier in Pediatric Research (2010)

  5. No Access

    Article

    Early inhaled nitric oxide in moderately hypoxemic preterm and term newborns with RDS: the RDS subgroup analysis of the Franco-Belgian iNO Randomized Trial.

    P. Truffert, J. Llado-Paris, J.-C. Mercier, M. Dehan in European Journal of Pediatrics (2003)

  6. No Access

    Article

    Dypiridamole, a cGMP phosphodiesterase inhibitor, transiently improves the response to inhaled nitric oxide in two newborns with congenital diaphragmatic hernia

    Introduction: Congenital diaphragmatic hernia (CDH) remains a frustating cause of respiratory failure associated with persistent pulmonary hypertension of the newborn (PPHN). Although in...

    B. Thébaud, C. Saizou, C. Farnoux, J. F. Hartman, J. C. Mercier in Intensive Care Medicine (1999)

  7. Article

    Disease-related response to inhaled nitric oxide in newborns with severe hypoxaemic respiratory failure

    Inhaled nitric oxide (iNO) has been shown to improve oxygenation in severe persistent pulmonary hypertension of the newborn (PPHN). However, PPHN is often associated with various lung diseases. Thus, response...

    J.-C. Mercier, T. Lacaze, L. Storme, J.-C. Rozé in European Journal of Pediatrics (1998)

  8. Article

    RT-PA for Thrombotic Complications in 16 Neonates 78

    C Farnoux, O Camard, D Pinquier, B Mesplès, J F Hartmann, N Schlegel in Pediatric Research (1996)

  9. Article

    Hemodynamics and oxygenation changes induced by the discontinuation of low-dose inhalational nitric oxide in newborn infants

    To assess changes associated with nitric oxide (NO) discontinuation in neonates receiving inhalational NO therapy as a treatment for pulmonary hypertension of the neonate (PPHN).

    M. Françoise, J. B. Gouyon, J. C. Mercier in Intensive Care Medicine (1996)